[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1981

Oral RetinoidsBroad-Spectrum Dermatologic Therapy for the 1980s

Author Affiliations

From the Department of Dermatology, University of Michigan Medical School, Ann Arbor (Dr Voorhees); and the Department of Dermatology, University Medical Center Steglitz, The Free University of Berlin (Dr Orfanos).

Arch Dermatol. 1981;117(7):418-421. doi:10.1001/archderm.1981.01650070046024
Abstract

Two new synthetic retinoids, isotretinoin (13-cis-retinoic acid) and etretinate (RO 10-9259) are now being studied. From Oct 13 through 15, 1980, an international symposium on retinoids in dermatology, organized by an international scientific committee (Profs C. E. Orfanos, Berlin; O. Braun-Falco, Munich, Germany; E. M. Farber, Stanford, Calif; C. Grupper, Paris; M. Polano, Leiden, the Netherlands; and R. Schuppli, Basel, Switzerland), was held at The Free University of Berlin. More than 400 participants representing 33 countries heard the results of recent basic and clinical research on the oral use of these remarkable new drugs. Historically, the availability of new pharmacologic agents has greatly influenced the development of dermatology. In the 1980s and 1990s, retinoids may revolutionize dermatologic therapy in a manner analogous to glucocorticoids in the 1950s and 1960s. For this reason, we believed that a report summarizing the highlights of the Berlin retinoid symposium would be of interest. (Remarks

First Page Preview View Large
First page PDF preview
First page PDF preview
×